Skip to main content
Clinical Trials/NCT01393275
NCT01393275
Completed
N/A

Effects of Exercise Intervention in Patients With Type 2 Diabetes - Strength Endurance Exercise Intervention Versus Combination of Strength Endurance Exercise Intervention and Rehabilitation Exercise Intervention

University of Giessen2 sites in 1 country68 target enrollmentFebruary 2010

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diabetes
Sponsor
University of Giessen
Enrollment
68
Locations
2
Primary Endpoint
alteration of HbA1c-level (haemoglobin A1c)
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The purposes of the study are

  • to determine if a supervised exercise intervention is improving the metabolic parameters in type 2 diabetes patients
  • to investigate what kind of intervention (strength endurance training versus combined strength endurance training and rehabilitation exercise intervention)is more effective in improving the metabolic parameters in patients with type 2 diabetes
  • to assess which exercise intervention induces higher effects to the metabolic rate and cardiac and pulmonary capacity
  • to investigate what kind of intervention includes highest effects in long term persistence of these positive effects
Registry
clinicaltrials.gov
Start Date
February 2010
End Date
October 2011
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Andree Hillebrecht

Akad. Rat

University of Giessen

Eligibility Criteria

Inclusion Criteria

  • diagnosis of type 2 diabetes (ADA criteria)
  • admitted diabetes treatment will be diet and oral hypoglycemic agents

Exclusion Criteria

  • sports intervention \> 60 minutes per week
  • medical conditions
  • proliferative retinopathy
  • instable coronary heart disease
  • acute clinically significant intercurrent disease
  • inability to perform scheduled physical activity programs

Outcomes

Primary Outcomes

alteration of HbA1c-level (haemoglobin A1c)

Time Frame: 6 months

Secondary Outcomes

  • alteration of total cholesterol level(6 months)
  • alteration of LDL-cholesterol-level(6 months)
  • alteration of HDL-cholesterol-level(6 months)
  • alteration of triglyceride-level(6 months)
  • alteration of antidiabetic medications(6 months)
  • alteration of anthropometry(6 months)
  • alteration of body composition(6 months)
  • alteration of resting metabolic rate(6 months)
  • alteration of blood pressure(6 months)
  • alteration of cardiac and pulmonary capacity(6 months)
  • alteration of quality of life(6 months)
  • follow up of all parameters mentioned above(15 months)

Study Sites (2)

Loading locations...

Similar Trials